Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hook

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
British Journal of Haematology|July 27, 2001
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasiaR A Mesa, A Tefferi, M A Elliott, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2020
An ATP-dependent partner switch links flagellar C-ring assembly with gene expressionVitan Blagotinsek, Meike Schwan, Wieland Steinchen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1996
Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experienceM Barton, J Boyages, E Crennan, et al.
British Journal of Haematology|August 4, 2021
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive casesKebede H Begna, Jaya Kittur, Jennifer Yui, et al.
Haematologica|March 7, 2024
Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative casesFaiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, et al.
Mayo Clinic Proceedings|August 6, 2019
Etiologies of Extreme Thrombocytosis: A Contemporary SeriesRonan W Hsieh, Aishwarya Ravindran, Christopher C Hook, et al.
American Journal of Hematology|June 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapyAyalew Tefferi, Naseema Gangat, Aref Al-Kali, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
British Journal of Haematology|July 27, 2001
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasiaR A Mesa, A Tefferi, M A Elliott, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2020
An ATP-dependent partner switch links flagellar C-ring assembly with gene expressionVitan Blagotinsek, Meike Schwan, Wieland Steinchen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1996
Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experienceM Barton, J Boyages, E Crennan, et al.
British Journal of Haematology|August 4, 2021
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive casesKebede H Begna, Jaya Kittur, Jennifer Yui, et al.
Haematologica|March 7, 2024
Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative casesFaiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, et al.
Mayo Clinic Proceedings|August 6, 2019
Etiologies of Extreme Thrombocytosis: A Contemporary SeriesRonan W Hsieh, Aishwarya Ravindran, Christopher C Hook, et al.
American Journal of Hematology|June 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapyAyalew Tefferi, Naseema Gangat, Aref Al-Kali, et al.
Pageof 6